Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Experimental PfSPZ Vaccine in Adults Without Malaria

This study has been completed.
Sponsor:
Collaborators:
Sanaria Incorporated
U.S. Military Malaria Vaccine Program
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT01441167
First received: September 24, 2011
Last updated: August 6, 2016
Last verified: June 2013